Differential diagnosis and early detection of dementia

American Journal of Geriatric Psychiatry

Volumn 6, Issue 2 SUPPL., 1998, Pages

  Small, Gaiy W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; DEMENTIA; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; GENETIC RISK; HUMAN; LABORATORY TEST; PATIENT MONITORING; REVIEW; SCREENING TEST;

EID: 0031901628     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019442-199821001-00004     Document Type: Article

References (42)

1. Advisory Panel on Alzheimer's Disease: Fourth Report of the Advisory on Alzheimer's Disease, 1992. Washington, DC, U.S. Government Printing Office, NIU Publication No. 93-3520, 1993
2. Ernst RW, Hay JL: The U.S. economic and social costs of Alzheimer's disease revisited. Am J Public Health 1994; 84:1261-1264
3. Ross GW, Abbott RD, Petrovitch H, et al: Frequency and characteristics of silent dementia among elderly Japanese-American men: the Honolulu Asia Aging Study. JAMA 1997; 277:800-805
4. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington, DC, American Psychiatric Association, 1994
5. Small GW, Jarvik LF: The dementia syndrome. Lancet 1982; 2:1443-1446
6. Risse SC, Raskind MA, Nochlin D, et al: Neuropathological findings in patients with clinical diagnoses of probable Alzheimer's disease. Am J Psychiatry 1990; 147:168-172
7. Alzheimer's Disease and Related Dementias Guidelines Panel: Recognition and Initial Assessment of Alzheimer's Disease and Related Dementias. Rockville, MD, U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, AHCPR Publication No. 97-0702, November 1996
8. Brust JC: Vascular dementia-still overdiagnosed. Stroke 1983; 14:298-300
9. Snowdon DA, Greiner LU, Mortimer JA, et al: Brain infarction and the clinical expression of Alzheimer disease: the Nun Study. JAMA 1997; 277:813-817
10. Larrabee GJ, Crook TU: Estimated prevalence of age-associated memory impairment derived from standardized tests of memory function. Int Psychogeriatr 1994; 6:95-104
11. Francis J, Kapoor WN: Prognosis after hospital discharge of older medical patients with delirium. J Am Geriatr Soc 1992; 40:601-606
12. Folstein M, Folstein S, McHugh P: "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
13. Mohs RC: Neuropsychological assessment of patients with Alzheimer's disease, in Psychopharmacology: The Fourth Generation of Progress, edited by Bloom FE, Kupfer DJ. New York, Raven, 1995
14. Motter R, Vigo-Pelfrey C, Kholodenko D, et al: Reduction of β-amyloid peptide 42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol 1995; 38:643-648
15. de Leon MJ, GolombJ, Georte AD, et al: The radiologic prediction of Alzheimer's disease: the atrophic hippocampal formation. Am J Neuroradiol 1993; 14:897-906
16. Jobst KA, Smith AD, Szatmari M, et al: Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet 1992; 340:1179-1183
17. Mazziotta JC, Frackowiak RSJ, Phelps ME: The use of positron emission tomography in the clinical assessment of dementia. Semin Nucl Med 1992; 22:233-246
18. Peppard RF, Martin W, Carr GE, et al: Cerebral glucose metabolism in Parkinson's disease with and without dementia. Arch Neurol 1992; 49:1262-1268
19. Lesser IM, Mena I, Boone KB, et al: Reduction of cerebral blood flow in older depressed patients. Arch Gen Psychiatry 1994; 51:6776-6786
20. Kumar A, Newberg A, Alavi A, et al: Regional cerebral glucose metabolism in late life depression and Alzheimer disease: a preliminary positron emission tomography study. Proc Natl Acad Sci 1993; 90:7019-7023
21. Sackeim HA, Prohovnik I, Moeller Jr, et al: Regional cerebral blood flow in mood disorders. II. Comparison of major depression and Alzheimer's disease. J Nucl Med 1993; 34:1090-1101
22. Kuhl DE, Small GW, Riege WH, et al: Cerebral metabolic patterns before the diagnosis of probable Alzheimer's disease. J Cereb Blood Flow Metab 1987; 7(suppl 1):S406
23. Haxby JV, Grady CL, Koss E, et al: Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch Neurol 1990; 47:753-760
24. Small GW, Mazziotta JC, Collins MT, et al: Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 1995; 273:942-947
25. Sherrington R, Rogaev EI, Liang Y, et al: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375:754-760
26. Levy-Lahad E, Wasco W, Poorkaj P, et al: Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995; 269:973- 977
27. Corder EH, Saunders AM, Strittmatter WJ, et al: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261:921-923
28. Goate A, Chartier-Harlin M-C, Mullan M, et al: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349:704-706
29. Saunders AM, Strittmatter WJ, Schmechel D, et al: Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43:1467-1472
30. Corder EH, Saunders AM, Risch MJ, et al: Apolipoprotein E type 2 allele and the risk of late onset Alzheimer's disease. Nature Genet 1994; 7:180-183
31. Duara R, Grady C, Haxby J, et al: Positron emission tomography in Alzheimer's disease. Neurology 1986; 36:879-887
32. Kippenhan SJ, Barker WW, Pascal S, et al: Evaluation of a neural-network classifier for PET scans of normal and Alzheimer's disease subjects. J Nucl Med 1992; 33:1459-1467
33. Herholz K, Adams R, Kessler J, et al: Criteria for the diagnosis of Alzheimer's disease with positron emission tomography. Dementia 1990; 1:156-164
34. Small GW, Okonek A, Mandelkern M, et al: Age-associated memory loss: initial neuropsychological and cerebral metabolic findings of a longitudinal study. Int Psychogeriatr 1994; 6:21-43
35. Benton AL, Hamsher K: Multilingual Aphasia Examination. Iowa City, IA, University of Iowa, 1976, revised 1978
36. Buschke H, Fuld PA: Evaluating storage, retention and retrieval in disordered memory and learning. Neurology 1974; 24:1019-1025
37. Small GW, La Rue A, Komo S, et al: Predictors of cognitive change in middle-aged and older adults with memory loss. Am J Psychiatry 1995b; 152:1757-1764
38. Reiman EM, Caselli RJ, Yun LS, et al: Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 1996; 334:752-758
39. Molchan SE, Matochik JA, Zametkin AJ, et al: A double FDG/PET study of the effects of scopolamine in older adults. Neuropsychopharmacol 1994; 10:191-198
40. Klunk WE, Debnath ML, Pettegrew JW: Development of small molecule probes for the beta-amyloid protein of Alzheimer's disease. Neurobiol Aging 1994; 15:691-698
41. Bookheimer SY, Dapretto M, Small G, et al: Hippocampal activation during memory acquisition and retrieval using functional MRI. Annual Meeting of the Society for Neuroscience. Washington, DC, November 16-21, 1996:967
42. Relkin NR, Tanzi R, Breitner J, et al: Apolipoprotein E genotyping in Alzheimer's disease: position statement of the National Institute on Aging/Alzheimer's Association Working Group. Lancet 1996; 347:1091-1095